These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 27578135)

  • 1. Metabolic syndrome is associated with muscle symptoms among statin users.
    Brinton EA; Maki KC; Jacobson TA; Sponseller CA; Cohen JD
    J Clin Lipidol; 2016; 10(4):1022-1029. PubMed ID: 27578135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle symptoms in statin users, associations with cytochrome P450, and membrane transporter inhibitor use: a subanalysis of the USAGE study.
    Ito MK; Maki KC; Brinton EA; Cohen JD; Jacobson TA
    J Clin Lipidol; 2014; 8(1):69-76. PubMed ID: 24528687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Provider recommendations for patient-reported muscle symptoms on statin therapy: Insights from the Understanding Statin Use in America and Gaps in Patient Education survey.
    Jacobson TA; Khan A; Maki KC; Brinton EA; Cohen JD
    J Clin Lipidol; 2018; 12(1):78-88. PubMed ID: 29239815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of statin adherence, switching, and discontinuation in the USAGE survey: understanding the use of statins in America and gaps in patient education.
    Wei MY; Ito MK; Cohen JD; Brinton EA; Jacobson TA
    J Clin Lipidol; 2013; 7(5):472-83. PubMed ID: 24079289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender differences in side effects and attitudes regarding statin use in the Understanding Statin Use in America and Gaps in Patient Education (USAGE) study.
    Karalis DG; Wild RA; Maki KC; Gaskins R; Jacobson TA; Sponseller CA; Cohen JD
    J Clin Lipidol; 2016; 10(4):833-841. PubMed ID: 27578114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleiotropic effects of metformin to rescue statin-induced muscle injury and insulin resistance: A proposed mechanism and potential clinical implications.
    Carris NW; Tipparaju SM; Magness DJ; Chapalamadugu KC; Magness RR
    Med Hypotheses; 2017 Sep; 107():39-44. PubMed ID: 28915960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin-associated muscle symptoms-Managing the highly intolerant.
    Backes JM; Ruisinger JF; Gibson CA; Moriarty PM
    J Clin Lipidol; 2017; 11(1):24-33. PubMed ID: 28391891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin-associated incident diabetes: a literature review.
    Park ZH; Juska A; Dyakov D; Patel RV
    Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
    Querton L; Buysschaert M; Hermans MP
    J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding Statin Use in America and Gaps in Patient Education (USAGE): an internet-based survey of 10,138 current and former statin users.
    Cohen JD; Brinton EA; Ito MK; Jacobson TA
    J Clin Lipidol; 2012; 6(3):208-15. PubMed ID: 22658145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with ETC-1002 alone and in combination with ezetimibe lowers LDL cholesterol in hypercholesterolemic patients with or without statin intolerance.
    Thompson PD; MacDougall DE; Newton RS; Margulies JR; Hanselman JC; Orloff DG; McKenney JM; Ballantyne CM
    J Clin Lipidol; 2016; 10(3):556-67. PubMed ID: 27206943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between dyslipidemia and vascular events in patients treated with statins: report from the UK General Practice Research Database.
    Sazonov V; Beetsch J; Phatak H; Wentworth C; Evans M
    Atherosclerosis; 2010 Jan; 208(1):210-6. PubMed ID: 19766999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of hypertension with small, dense low-density lipoprotein in patients without metabolic syndrome.
    Kim YK; Seo HS; Lee EM; Na JO; Choi CU; Lim HE; Kim EJ; Rha SW; Park CG; Oh DJ
    J Hum Hypertens; 2012 Nov; 26(11):670-6. PubMed ID: 21975689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update.
    Reiner Z
    Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):799-807. PubMed ID: 23932901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol levels and statin use in patients with coronary heart disease treated in primary care settings.
    O'Connor PJ; Gray RJ; Maciosek MV; Fillbrandt KM; DeFor TA; Alexander CM; Weiss TW; Teutsch SM
    Prev Chronic Dis; 2005 Jul; 2(3):A05. PubMed ID: 15963307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of ETC-1002 to treat hypercholesterolemia in patients with statin intolerance.
    Thompson PD; Rubino J; Janik MJ; MacDougall DE; McBride SJ; Margulies JR; Newton RS
    J Clin Lipidol; 2015; 9(3):295-304. PubMed ID: 26073387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of statin use and hypertriglyceridemia with diabetic macular edema in patients with type 2 diabetes and diabetic retinopathy.
    Chung YR; Park SW; Choi SY; Kim SW; Moon KY; Kim JH; Lee K
    Cardiovasc Diabetol; 2017 Jan; 16(1):4. PubMed ID: 28061854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome cluster does not provide incremental prognostic information in patients with stable cardiovascular disease: A post hoc analysis of the AIM-HIGH trial.
    Lyubarova R; Robinson JG; Miller M; Simmons DL; Xu P; Abramson BL; Elam MB; Brown TM; McBride R; Fleg JL; Desvigne-Nickens P; Ayenew W; Boden WE;
    J Clin Lipidol; 2017; 11(5):1201-1211. PubMed ID: 28807460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.